Disease Quiz
... Primary: early intervention to avoid initial exposure to agent of disease preventing process from starting. ...
... Primary: early intervention to avoid initial exposure to agent of disease preventing process from starting. ...
TB Disease
... antibiotics. Treatment usually lasts from 6-9 months • By taking the medication until you are cured, you protect your family and friends from TB ...
... antibiotics. Treatment usually lasts from 6-9 months • By taking the medication until you are cured, you protect your family and friends from TB ...
Bloodborne Pathogens/TB
... In 2005 AIDS claimed 2.4-3.3 million lives of which, more than 570,000 were children. It is one of the most destructive pandemics in recorded history. ...
... In 2005 AIDS claimed 2.4-3.3 million lives of which, more than 570,000 were children. It is one of the most destructive pandemics in recorded history. ...
Shelter Dogs as Sentinels for T. cruzi
... autochthonous transmission is increasingly recognized (3), and enzootic cycles involving infected wildlife reservoirs and domestic dogs occur across the southern United States. (4). Vectorborne transmission occurs through contamination of the bite site or mucous membranes with feces of infected hema ...
... autochthonous transmission is increasingly recognized (3), and enzootic cycles involving infected wildlife reservoirs and domestic dogs occur across the southern United States. (4). Vectorborne transmission occurs through contamination of the bite site or mucous membranes with feces of infected hema ...
Tuberculosis (TB) Fact Sheet for EMS, Public Safety, and First
... who may need TB skin testing? Hospitals conduct a contact investigation when an unisolated patient with potentially infectious TB is identified. This investigation should include public safety personnel and first responders. A TB contact investigation uses a concentric circle approach and may take s ...
... who may need TB skin testing? Hospitals conduct a contact investigation when an unisolated patient with potentially infectious TB is identified. This investigation should include public safety personnel and first responders. A TB contact investigation uses a concentric circle approach and may take s ...
HONG KONG—A Chinese health expert has suggested that hand
... Health Minister Chen Zhu on Wednesday blamed low-quality medical systems for the inability to spot some health threats. The state-run Xinhua news agency said that as of Friday, officials had reported 41,846 cases of hand, foot, and mouth disease, which breaks out early each year in China. Last year' ...
... Health Minister Chen Zhu on Wednesday blamed low-quality medical systems for the inability to spot some health threats. The state-run Xinhua news agency said that as of Friday, officials had reported 41,846 cases of hand, foot, and mouth disease, which breaks out early each year in China. Last year' ...
Slide 1
... The purposes of epidemiology are: 1. to define distribution and size of disease problems within and between populations; 2. to understand reservoirs and transmission of infections; 3. to identify contributing factors in pathogenesis of the disease (who has predisposing factors and are most at risk? ...
... The purposes of epidemiology are: 1. to define distribution and size of disease problems within and between populations; 2. to understand reservoirs and transmission of infections; 3. to identify contributing factors in pathogenesis of the disease (who has predisposing factors and are most at risk? ...
Disorders - Resp.system
... uncontrolled cell growth in tissues of the lung •The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss. •Treatment: Surgery, chemotherapy, radiation ...
... uncontrolled cell growth in tissues of the lung •The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss. •Treatment: Surgery, chemotherapy, radiation ...
An acute bacterial disease, characterized by sudden onset of fever
... of infected people; Up to 5%–10% of people may be asymptomatic carriers with nasopharyngeal colonization by N. meningitidis. Less than 1% of those colonized will progress to invasive disease. Carrier rates of 25% have been documented in some populations. ...
... of infected people; Up to 5%–10% of people may be asymptomatic carriers with nasopharyngeal colonization by N. meningitidis. Less than 1% of those colonized will progress to invasive disease. Carrier rates of 25% have been documented in some populations. ...
Lyme Disease Bacterium Came From Europe Before Ice Age
... present in North America for a long time. The researchers suggest its re-emergence there in the 1970s occurred after the geographic territory of the tick that carries the bacteria expanded, for example through the restoration of woodland. Lyme disease is a growing problem in Europe, Asia and - in pa ...
... present in North America for a long time. The researchers suggest its re-emergence there in the 1970s occurred after the geographic territory of the tick that carries the bacteria expanded, for example through the restoration of woodland. Lyme disease is a growing problem in Europe, Asia and - in pa ...
Diseases Caused by Bacteria & Viruses
... causing agent – Interferes w/normal activities of body ...
... causing agent – Interferes w/normal activities of body ...
Test Word Lists
... Antigenicity (Immunogenicity)ability of an agent to induce antibody production in host. Toxicity/Toxigenicity-ability of an agent to produce a toxin or poison. Virulence-severity of disease (case fatality rate) Resistance-ability of the agent to survive adverse environmental conditions Mediators-che ...
... Antigenicity (Immunogenicity)ability of an agent to induce antibody production in host. Toxicity/Toxigenicity-ability of an agent to produce a toxin or poison. Virulence-severity of disease (case fatality rate) Resistance-ability of the agent to survive adverse environmental conditions Mediators-che ...
HLSC 3623 Human Diseases
... Antigenicity (Immunogenicity)ability of an agent to induce antibody production in host. Toxicity/Toxigenicity-ability of an agent to produce a toxin or poison. Virulence-severity of disease (case fatality rate) Resistance-ability of the agent to survive adverse environmental conditions Mediators-che ...
... Antigenicity (Immunogenicity)ability of an agent to induce antibody production in host. Toxicity/Toxigenicity-ability of an agent to produce a toxin or poison. Virulence-severity of disease (case fatality rate) Resistance-ability of the agent to survive adverse environmental conditions Mediators-che ...
Equine Infectious Anaemia.
... What is the Cause? The cause is a virus from the same family as HIV, therefore, the virus of EIA is also quite good at evading the host’s immune system and infected horses remain infected (positive) for the rest of their lives. They therefore, act as a potential source of infection. How is it spread ...
... What is the Cause? The cause is a virus from the same family as HIV, therefore, the virus of EIA is also quite good at evading the host’s immune system and infected horses remain infected (positive) for the rest of their lives. They therefore, act as a potential source of infection. How is it spread ...
Sexual Transmitted Infection/Disease Research
... 1. Define “Sexually Transmitted Infection” (provide your source of ...
... 1. Define “Sexually Transmitted Infection” (provide your source of ...
Infection and it`s mode of transmission:
... A Carrier is defined as an infected person or animal that harbours a specific infectious agent in the absence of discernible clinical disease and serves as a potential source of infection for others A) Incubatory ► TYPE B) Convalescent C) Healthy ► DURATION A) Temporary B) Chronic PORTAL OF EXIT: A) ...
... A Carrier is defined as an infected person or animal that harbours a specific infectious agent in the absence of discernible clinical disease and serves as a potential source of infection for others A) Incubatory ► TYPE B) Convalescent C) Healthy ► DURATION A) Temporary B) Chronic PORTAL OF EXIT: A) ...
Blood and Tissue Protozoa of Dogs and Cats
... of the female. One dog may have as many as 300 worms present when diagnosed. ...
... of the female. One dog may have as many as 300 worms present when diagnosed. ...
1. Precaution Lymphocytic choriomeningitis (LCM) is a rodent
... Humans become infected by inhaling infectious aerosolized particles of rodent urine, feces, or saliva; by ingesting food contaminated with virus; by contamination of mucous membranes with infected body fluids; o ...
... Humans become infected by inhaling infectious aerosolized particles of rodent urine, feces, or saliva; by ingesting food contaminated with virus; by contamination of mucous membranes with infected body fluids; o ...
Infection, mimics, and autoimmune disease Commentary
... mice infected with T. cruzi, was found in abundance in human and mouse hearts. Cross-reaction between the mammalian and trypanosomal peptides was documented for both T and B cells. The finding that this peptide bears both B- and T-cell epitopes makes it a leading candidate for the induction of the c ...
... mice infected with T. cruzi, was found in abundance in human and mouse hearts. Cross-reaction between the mammalian and trypanosomal peptides was documented for both T and B cells. The finding that this peptide bears both B- and T-cell epitopes makes it a leading candidate for the induction of the c ...
Filariae
... primarily on the extremities lasting up to 3 days. Subcutaneous adult organisms are large enough to be visible (they rarely migrate across the conjunctiva). Among individuals from endemic areas, infection is usually asymptomatic with microfilaremia and a ...
... primarily on the extremities lasting up to 3 days. Subcutaneous adult organisms are large enough to be visible (they rarely migrate across the conjunctiva). Among individuals from endemic areas, infection is usually asymptomatic with microfilaremia and a ...
Fighting Disease
... • Passive- Antibodies come from another source other than body (immunity passed from mother to baby at birth) ...
... • Passive- Antibodies come from another source other than body (immunity passed from mother to baby at birth) ...
Aim: To explain the distribution of diseases of affluence
... Aim: To explain the distribution of diseases of affluence and poverty ...
... Aim: To explain the distribution of diseases of affluence and poverty ...
Chagas disease
Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan Trypanosoma cruzi. It is spread mostly by insects known as triatominae or kissing bugs. The symptoms change over the course of the infection. In the early stage, symptoms are typically either not present or mild and may include fever, swollen lymph nodes, headaches, or local swelling at the site of the bite. After 8–12 weeks, individuals enter the chronic phase of disease and in 60–70% it never produces further symptoms. The other 30 to 40% of people develop further symptoms 10 to 30 years after the initial infection, including enlargement of the ventricles of the heart in 20 to 30%, leading to heart failure. An enlarged esophagus or an enlarged colon may also occur in 10% of people.T. cruzi is commonly spread to humans and other mammals by the blood-sucking ""kissing bugs"" of the subfamily Triatominae. These insects are known by a number of local names, including: vinchuca in Argentina, Bolivia, Chile and Paraguay, barbeiro (the barber) in Brazil, pito in Colombia, chinche in Central America, and chipo in Venezuela. The disease may also be spread through blood transfusion, organ transplantation, eating food contaminated with the parasites, and by vertical transmission (from a mother to her fetus). Diagnosis of early disease is by finding the parasite in the blood using a microscope. Chronic disease is diagnosed by finding antibodies for T. cruzi in the blood.Prevention mostly involves eliminating kissing bugs and avoiding their bites. Other preventative efforts include screening blood used for transfusions. A vaccine has not been developed as of 2013. Early infections are treatable with the medication benznidazole or nifurtimox. Medication nearly always results in a cure if given early, but becomes less effective the longer a person has had Chagas disease. When used in chronic disease, medication may delay or prevent the development of end–stage symptoms. Benznidazole and nifurtimox cause temporary side effects in up to 40% of people including skin disorders, brain toxicity, and digestive system irritation.It is estimated that 7 to 8 million people, mostly in Mexico, Central America and South America, have Chagas disease as of 2013. In 2006, Chagas was estimated to result in 12,500 deaths per year. Most people with the disease are poor, and most people with the disease do not realize they are infected. Large-scale population movements have increased the areas where Chagas disease is found and these include many European countries and the United States. These areas have also seen an increase in the years up to 2014. The disease was first described in 1909 by Carlos Chagas after whom it is named. It affects more than 150 other animals.